New delivery device for inhaled drugs for bronchial asthma treatment. Multidose Easyhaler dry powder inhaler
- Authors: Vilegzhanina TG1
-
Affiliations:
- Institute of Immunology
- Issue: Vol 11, No 2 (2014)
- Pages: 37-40
- Section: Articles
- URL: https://bakhtiniada.ru/raj/article/view/120841
- DOI: https://doi.org/10.36691/RJA509
- ID: 120841
Cite item
Open Access
Access granted
Subscription Access
Abstract
According to current conception of bronchial asthma treatment, the main goals are symptoms control and good life quality. Inhalation is the preferred route of drug administration for patients with airway diseases such as asthma. Inhalation delivers drugs directly to the airways and thereby the effective dose can be small compared with oral therapy (in 20 times), the risk of systemic side effects is reduced, it could be used for poorly soluble drugs which are not absorbed in the gastrointestinal canal. Inhalation is the route of drug administration and can be used for delivery of bronchodilators, mucolytics, steroids, and cromoglicate acid drugs as well.
Keywords
Full Text
##article.viewOnOriginalSite##References
- Вылегжанина Т.Г., Ильина Н.И. Беклометазон Эко Легкое Дыхание - «золотой стандарт» базисной терапии бронхиальной астмы. Consilium medicum, приложение Пульмонология. 2006, с. 14-18.
- Вылегжанина Т.Г. Выбор средств доставки ингаляционных глюкокортикостероидов для лечения бронхиальной астмы. Беклоджет как система безопасности и клинической эффективности терапии. Рос. Аллергол. Журн. 2005, № 4, с. 77-83.
- Yung Sung Cheng. Mechanisms of pharmaceutical aerosol deposition in the respiratory tract. AAPS Pharm. Sci. Tech. 2014.
- Edbasker S. Pharmacological factors that influence the choice of inhaled corticosteroids. Drug. 1999, v. 58, p. 7-16.
- Newman S.P., Weisz A.W.B., Talaee N. et al. Improvement of drug delivery with a breath actuated pressurized aerosol for patients with poor inhaler technique. Thorax. 1991, v. 46, p. 712-716.
- Ganderton D., Lewis D., Davies R. et al. Modulite T: a means of designing the aerosol generated by pressurized metered dose inhalers. Respir. Med. 2002, v. 96, p. 3-8.
- Palander A., Mattila T., Karhu M., Muttonen E. In vitro comparison of three salbutamol containing multidose dry powder inhalers. Buventol Easyhaler, Inspiryl Turbuhaler and Ventoline Diskus. Clin Drug Invest. 2000, v. 20, p. 25-33.
- Väänänen A., Mattila T., Hanhineva P. et al. In vitro particle characteristics of budesonide containing MDI and DPI products. Eur. Resp. J. 2002, v. 20, p. 33-55.
- Koskela T., Mlmstrom K., Sairanen U. et al. Efficacy of salbutamol via Easyhaler unaffected by low inspiratory flow. Resp. Med. 2000, v. 94, p. 1229-1233.
- Kaukonen K., Sorva R. Peak inspiratory flow via a novel multi-dose powder inhaler in children (abstract). Eur. Respir. J. 1995, v. 8, 208 p.
- Vidgren M., Arppe J., Vidgren P. et al. Pulmonary deposition of 99m Tclabelled salbutamol particles in healthy volunteers after inhalation from a metered-dose inhaler and from a novel multiple-dose powder inhaler. Stp. Pharma Sci. 1994, v. 4, p. 29-32.
- Hämäläinen K.M., Granander M., Toivanen P. et al. Assessment of the systemic effects of budesonide inhaled from Easyhaler and from Turbuhaler in healthy male volunteers. Resp. Med. 2001, v. 95, p. 863-869.
- Lähelmä S., Kirjavainen M., Kela M. et al. Equivalent lung deposition of budesonide in vivo: a comparison of dry powder inhalers using a pharmacokinetic method. Br. J. Clin. Pharmacol. 2004, v. 59, p. 167-173.
- Tukiainen H., Rytilä P., Hämäläinen K.M. et al. Safety, tolerability and acceptability of two dry powder inhalers in the administration of budesonide in steroid-treated asthmatic patients. Resp. Med. 2002, v. 96, p. 221-229.
- Schweisfurth H., Malinen A., Koskela T. et al. Comparison of two budesonide powder inhalers, Easyhaler and from Tur buhaler in steroid-naïve asthmatic patients. Resp. Med. 2002, v. 96, p. 599-606.
- Панина Н.Т., Илькович М.М. Изихейлеры в практике лечения больных бронхиальной астмой. Тер. архив. 2013, № 3, с. 98-101.
Supplementary files
